Skip to main content

Gennadios Aristippos

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Gennadios Aristippos as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 5, 2024 (view filing)Aug 23 daysGennadios AristipposGroup Pres. Pharma & ConsumerSSale−1.17K$59.55−$69.6K−1.0%113.7K after
Jul 30, 2024 (view filing)Jul 291 dayGennadios AristipposGroup Pres. Pharma & ConsumerSSale−349$58.70−$20.5K−0.3%114.9K after
Aug 3, 2023 (view filing)Aug 12 daysGennadios AristipposGroup Pres. Pharma & ConsumerSSale−281$47.59−$13.4K−0.3%86.5K after2 lots
Aug 26, 2022 (view filing)Aug 251 dayGennadios AristipposGroup Pres. Pharma & ConsumerSSale−1.65K$103.04−$169.5K−1.9%86.8K after
Jul 28, 2022 (view filing)Jul 262 daysGennadios AristipposGroup Pres. Pharma & ConsumerSSale−403$106.90−$43.1K−0.5%79.8K after
Aug 30, 2021 (view filing)Aug 273 daysGennadios AristipposPresident Softgel & Oral TechSSale−2.26K$131.13−$296.6K−3.8%57.5K after2 lots
Jul 28, 2021 (view filing)Jul 262 daysGennadios AristipposPresident Softgel & Oral TechSSale−465$113.05−$52.6K−0.9%50.9K after